TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma

BACKGROUND: The role of tumor necrosis factor alpha (TNF-α) in targeted therapy for hepatocellular carcinoma (HCC) remains largely unknown. The current study aimed to clarify the mechanistic effects of targeting TNF-α to overcome sorafenib resistance in HCC. METHODS: A correlation of TNF-α expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Wenliang, Luo, Xuan, Li, Wenda, Zhong, Jinyi, Cao, Jun, Zhu, Sicong, Chen, Xianqing, Zhou, Rui, Shang, Changzhen, Chen, Yajin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412090/
https://www.ncbi.nlm.nih.gov/pubmed/30594557
http://dx.doi.org/10.1016/j.ebiom.2018.12.047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412090/
https://www.ncbi.nlm.nih.gov/pubmed/30594557
http://dx.doi.org/10.1016/j.ebiom.2018.12.047

Ejemplares similares